316 related articles for article (PubMed ID: 21109969)
21. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
[TBL] [Abstract][Full Text] [Related]
22. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
23. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.
Golestaneh AF; Atashi A; Langroudi L; Shafiee A; Ghaemi N; Soleimani M
Cell Biochem Funct; 2012 Jul; 30(5):411-8. PubMed ID: 22374783
[TBL] [Abstract][Full Text] [Related]
24. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
[TBL] [Abstract][Full Text] [Related]
25. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
26. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.
Zhang Q; Shi S; Yen Y; Brown J; Ta JQ; Le AD
Cancer Lett; 2010 Mar; 289(2):151-60. PubMed ID: 19748175
[TBL] [Abstract][Full Text] [Related]
27. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
28. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
30. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
31. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
32. DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers.
Kim KH; Kang YJ; Jo JO; Ock MS; Moon SH; Suh DS; Yoon MS; Park ES; Jeong N; Eo WK; Kim HY; Cha HJ
Biochem Biophys Res Commun; 2014 May; 447(2):315-22. PubMed ID: 24727449
[TBL] [Abstract][Full Text] [Related]
33. Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549.
Lin S; Sun JG; Wu JB; Long HX; Zhu CH; Xiang T; Ma H; Zhao ZQ; Yao Q; Zhang AM; Zhu B; Chen ZT
Mol Cells; 2012 Mar; 33(3):277-83. PubMed ID: 22349807
[TBL] [Abstract][Full Text] [Related]
34. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
35. Limits of CD133 as a marker of glioma self-renewing cells.
Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
[TBL] [Abstract][Full Text] [Related]
36. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M
BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD133-1 and CD133-2 in ovarian cancer.
Ferrandina G; Bonanno G; Pierelli L; Perillo A; Procoli A; Mariotti A; Corallo M; Martinelli E; Rutella S; Paglia A; Zannoni G; Mancuso S; Scambia G
Int J Gynecol Cancer; 2008; 18(3):506-14. PubMed ID: 17868344
[TBL] [Abstract][Full Text] [Related]
38. Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
Zarif MN; Soleimani M; Abolghasemi H; Amirizade N; Arefian E; Rahimian A
Hematology; 2013 Mar; 18(2):93-100. PubMed ID: 23321646
[TBL] [Abstract][Full Text] [Related]
39. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
40. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
